Hydrochloric Acid → 5-cyclopropyl-2-(4-hydroxyphenyl)-6-[(3-hydroxypropyl)(methylsulfonyl)amino]-N-methyl-2H-indazole-3-carboxamide

HRID 1037544Notes

Reaction equation

HRID 1037544 reaction equation
Br[C:2]1[CH:7]=[CH:6][C:5]([N:8]2[C:16]([C:17]([NH:19][CH3:20])=[O:18])=[C:15]3[C:10]([CH:11]=[C:12]([N:24]([CH2:29][CH2:30][CH2:31][OH:32])[S:25]([CH3:28])(=[O:27])=[O:26])[C:13]([CH:21]4[CH2:23][CH2:22]4)=[CH:14]3)=[N:9]2)=[CH:4][CH:3]=1.[OH-:33].[K+].Cl>O1CCOCC1.O.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH:21]1([C:13]2[C:12]([N:24]([CH2:29][CH2:30][CH2:31][OH:32])[S:25]([CH3:28])(=[O:27])=[O:26])=[CH:11][C:10]3[C:15](=[C:16]([C:17]([NH:19][CH3:20])=[O:18])[N:8]([C:5]4[CH:6]=[CH:7][C:2]([OH:33])=[CH:3][CH:4]=4)[N:9]=3)[CH:14]=2)[CH2:23][CH2:22]1

Participants

7

Reactant 3

HCID 313Hydrochloric AcidHCID 14797Potassium HydroxideHCID 569627692-(4-bromophenyl)-5-cyclopropyl-6-[3-hydroxypropyl(methylsulfonyl)amino]-N-methyl-indazole-3-carboxamide

Product 1

HCID 675170055-cyclopropyl-2-(4-hydroxyphenyl)-6-[(3-hydroxypropyl)(methylsulfonyl)amino]-N-methyl-2H-indazole-3-carboxamideYield 109%

Reagents, catalysts & solvents 3

HCID 9811564Bis(dibenzylideneacetone)palladiumCatalystHCID 962WaterSolventHCID 312751,4-DioxaneSolvent

Conditions

Temperature
100 °C

Procedure

2-(4-Bromophenyl)-5-cyclopropyl-6-[(3-hydroxypropyl)(methylsulfonyl)amino]-N-methyl-2H-indazole-3-carboxamide (i) (16 mg, 0.031 mmol) in 1,4-dioxane (0.5 mL) had a solution of potassium hydroxide (9 mg, 0.016 mmol) in water (0.5 mL) added and was degassed. tert-Butyl-XPhos (4 mg, 0.009 mmol) and Pd2(dba)3 (4 mg, 0.004 mmol) were added and the reaction was heated at 100° C. for 4 h. The mixture was cooled to RT, 1 M hydrochloric acid (0.5 mL) was added and this was then concentrated to dryness. The residue was purified by reverse phase flash column chromatography eluting with ACN/water (5-100%) to afford 5-cyclopropyl-2-(4-hydroxyphenyl)-6-[(3-hydroxypropyl)(methylsulfonyl)amino]-N-methyl-2H-indazole-3-carboxamide (ii) as a white solid (8 mg, 57%).

Workup

  1. additionadded
  2. customwas degassed
  3. temperatureThe mixture was cooled to RT
  4. concentrationthis was then concentrated to dryness
  5. customThe residue was purified by reverse phase flash column chromatography
  6. washeluting with ACN/water (5-100%)

Sources & evidence

ORD record
ord-f2eb5e5fd6be498d88f4ce788ba5ee69
Source dataset
uspto-grants-2013_10
Patent number
US08546389B2

Reaction notes

Loading…